High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas

Katsuto Takenaka, Katsuji Shinagawa, Yoshinobu Maeda, Masanori Makita, Teruhiko Kozuka, Atsuko Ashiba, Kazuhiko Yamamoto, Nobuharu Fujii, Yuichiro Nawa, Yasushi Hiramatsu, Kazutaka Sunami, Fumihiko Ishimaru, Tadashi Yoshimo, Katsuyuki Kiura, Mine Harada

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

CD56+ natural killer (NK) cell lymphomas occur frequently in the nasal and nasopharyngeal regions and carry a poor prognosis. We have studied seven cases with NK-cell lymphomas. These lymphomas showed the following immunophenotype: CD56+, CD2+, sCD3- and Epstein-Barr virus-encoded small RNAs (EBERs)+. Six patients had localized (stage I or II) disease involving the nasopharyngeal region, while one had stage III disease. One patient with stage I disease achieved a complete remission (CR) after treatment with involved-field irradiation, but subsequently relapsed and died. The remaining six patients received combination chemotherapy as primary treatment: five patients with localized stage I or II disease and one patient with advanced stage III disease. Responses to initial chemotherapy were generally poor. These six patients received a variety of salvage chemotherapy regimens, but never achieved a CR. Subsequently, four of six patients showed a highly aggressive clinical course and died of disseminated disease within 1 year from the diagnosis. Three of six patients received high-dose chemotherapy supported by syngeneic, autologous or allogeneic peripheral blood stem cell transplantation. Two of the three transplant patients achieved a CR and are now surviving in continuous CR. Our clinical experience suggests that myeloablative high-dose chemotherapy and bone marrow rescue by hematopoietic stem cell transplantation may be an effective salvage treatment modality for refractory NK-cell lymphomas and could be considered as a part of the initial therapy for these patients.

Original languageEnglish
Pages (from-to)1297-1303
Number of pages7
JournalLeukemia and Lymphoma
Volume42
Issue number6
DOIs
Publication statusPublished - Dec 1 2001

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Cite this